Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Department of Biology, Johns Hopkins University, Baltimore, MD.
Blood. 2022 Sep 8;140(10):1119-1131. doi: 10.1182/blood.2022015926.
Unique molecular vulnerabilities have been identified in the aggressive MCD/C5 genetic subclass of diffuse large B-cell lymphoma (DLBCL). However, the premalignant cell-of-origin exhibiting MCD-like dependencies remains elusive. In this study, we examined animals carrying up to 4 hallmark genetic lesions found in MCD consisting of gain-of-function mutations in Myd88 and Cd79b, loss of Prdm1, and overexpression of BCL2. We discovered that expression of combinations of these alleles in vivo promoted a cell-intrinsic accumulation of B cells in spontaneous splenic germinal centers (GCs). As with MCD, these premalignant B cells were enriched for B-cell receptors (BCRs) with evidence of self-reactivity, displayed a de novo dependence on Tlr9, and were more sensitive to inhibition of Bruton's tyrosine kinase. Mutant spontaneous splenic GC B cells (GCB) showed increased proliferation and IRF4 expression. Mice carrying all 4 genetic lesions showed a >50-fold expansion of spontaneous splenic GCs exhibiting aberrant histologic features with a dark zone immunophenotype and went on to develop DLBCL in the spleen with age. Thus, by combining multiple hallmark genetic alterations associated with MCD, our study identifies aberrant spontaneous splenic GCBs as a likely cell-of-origin for this aggressive genetic subtype of lymphoma.
在侵袭性 MCD/C5 弥漫性大 B 细胞淋巴瘤(DLBCL)的遗传亚类中,已经确定了独特的分子脆弱性。然而,表现出 MCD 样依赖性的前恶性细胞起源仍然难以捉摸。在这项研究中,我们检查了携带多达 4 种在 MCD 中发现的标志性遗传病变的动物,这些病变包括 Myd88 和 Cd79b 的功能获得性突变、Prdm1 的缺失和 BCL2 的过表达。我们发现,这些等位基因组合在体内的表达促进了自发脾脏生发中心(GC)中 B 细胞的内在积累。与 MCD 一样,这些前恶性 B 细胞富含具有自身反应性证据的 B 细胞受体(BCR),表现出新的对 Tlr9 的依赖性,并且对 Bruton 酪氨酸激酶抑制更为敏感。突变的自发脾脏 GC B 细胞(GCB)表现出更高的增殖和 IRF4 表达。携带所有 4 种遗传病变的小鼠自发性脾脏 GC 显著扩张,表现出异常的组织学特征,具有暗区免疫表型,并随着年龄的增长在脾脏中发展为 DLBCL。因此,通过结合与 MCD 相关的多个标志性遗传改变,我们的研究确定异常自发脾脏 GCB 可能是这种侵袭性遗传亚型淋巴瘤的起源细胞。